Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.
Plotkin SR, Halpin C, Blakeley JO, Slattery WH 3rd, Welling DB, Chang SM, Loeffler JS, Harris GJ, Sorensen AG, McKenna MJ, Barker FG 2nd.
J Neurooncol. 2009 May;93(1):61-77. Epub 2009 May 9. Review.PMID: 19430883 [PubMed - indexed for MEDLINE]Related articles